翻訳と辞書 |
Durata Therapeutics : ウィキペディア英語版 | Durata Therapeutics Durata Therapeutics, established in 2009 in Morristown, New Jersey, is a clinical development stage pharmaceutical company which focuses on the treatment of infectious diseases. The company acquired dalbavancin, a long-acting semisynthetic lipoglycopeptide antibiotic, from Pfizer in December 2009.〔(Durata Therapeutics Acquires Pfizer’s Subsidiary that Develops Antibiotics. ) GEN News Highlights: Dec 21, 2009.〕 Durata has initiated two Phase III studies of dalbavancin for intravenous (IV) treatment of acute bacterial skin and skin structure infections.〔(Durata Begins Dalbavancin Study Enrollment. ) Drug Discovery & Development - October 05, 2011.〕 In 2012, the company moved its global headquarters from Morristown to Chicago in a deal with $2 million in tax credits. In October of 2014 Durata was acquired by Actavis for about $675 million.〔http://www.fiercebiotech.com/story/actavis-snaps-durata-newly-approved-antibiotic-675m-buyout/2014-10-06〕 ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Durata Therapeutics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|